Miura Partners Acquires HTBA (HealthTech BioActives)

The Riverside Company Acquires HealthTech BioActives (HTBA) from Ferrer

December 13, 2019

Pharmaceuticals

The Riverside Company has acquired HealthTech BioActives S.L. (HTBA), a Spanish manufacturer of APIs, excipients, natural flavors and vitamin B12 derivatives, in a carve-out from Ferrer. Riverside will work with HTBA’s ~140 employees and its manufacturing sites in Beniel (Murcia) and Barcelona to strengthen commercial capabilities, accelerate new product development and expand global sales.

Montagu Acquires Majority Stake in HTL Biotechnology

February 28, 2022

Pharmaceuticals

Montagu, a leading private equity firm, has acquired a majority stake in HTL (HTL Biotechnology) from Bridgepoint, with minority shareholders Naxicap and Téthys Invest retaining their holdings. Montagu will support HTL's international expansion, R&D and premium product positioning and has appointed Paul Navarre as Chairman to help drive the company's next growth phase.

Charme Capital Partners and Miura Capital Acquire INDIBA from Magnum

February 28, 2022

Medical Devices

Private equity firms Charme Capital Partners and Miura Capital have completed the acquisition of INDIBA, a Barcelona-based developer of 448 kHz radio-frequency medical devices for physiotherapy, aesthetics and veterinary markets, from Magnum. The deal positions INDIBA for a next phase of growth, with plans to expand market reach, product portfolio and operations under the new ownership.

Miura Partners Acquires 20% Stake in Bianna to Launch Bianna Renting Services

May 23, 2024

Environmental Services

Miura Partners' Impact Fund acquired a 20% stake in Bianna through a capital increase to fund the company's expansion and to create Bianna Renting Services, a rental business for waste treatment equipment and turnkey solutions. Bianna, founded in 1990 and based in Girona, Spain, operates globally with four production centers and six commercial branches, employs over 200 people and reported revenues above €50 million in 2023.

USANA Health Sciences Acquires 78.8% Stake in Hiya Health

December 23, 2024

Consumer Products

USANA Health Sciences acquired a 78.8% controlling stake in Hiya Health Products, LLC for approximately $205 million in cash, closing December 23, 2024. The acquisition expands USANA's direct-to-consumer presence in the children's health and wellness market and is expected to be accretive to USANA's 2025 adjusted EBITDA.

Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation

February 7, 2025

Pharmaceuticals

Bain Capital has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (MTPC) in a carve-out from Mitsubishi Chemical Group Corporation for approximately 510 billion JPY (about $3.3 billion). The deal, led by Bain’s Private Equity teams in Asia and North America together with its Life Sciences group, will create an independent, standalone Japanese pharma platform focused on drug discovery and development across immunology, CNS, vaccines, diabetes and other priority areas; the transaction is expected to close in Q3 2025.